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Summary
Objective: Chronic obstructive pulmonary disease (COPD) is a slowly progressive
condition characterised by poorly reversible airflow limitation associated with an
abnormal inflammatory response of the lung. The main causal factors of COPD are
chronic oxidative stress as a result of long-term smoking, use of biomass fuels, and
air pollution. In this study, basal levels of DNA strand breaks were investigatedee front matter & 2005
med.2005.10.011
ing author. Yenisehir
1.
ess: drerkanceylan@yahtogether with some additional oxidative markers implicating oxidative damage on
the other biomolecules such as proteins and lipids in patients with COPD who were
exposed to smoking and biomass.
Material and methods: We detected DNA strand breaks in peripheral blood
mononuclear leukocytes by using a Single Cell Gel Electrophoresis (also called
Comet Assay), plasma protein carbonyl (PC) content by using Reznick and Parker’s
spectrophotometric method, and lipid peroxidation by measurement of malondial-
dehyde (MDA) as indexes of oxidative stress in 47 patients with smoking-related
COPD and 25 patients with biomass-related COPD and 36 age-and-sex matched
control participants.
Results: The mean values of DNA strand breaks, MDA and protein carbonyl levels
were significantly higher in smoking- and biomass-related COPD groups than in the
control group (ANOVA Po0.001, o0.05 and o0.05, respectively). DNA damage
levels were also higher in smoking-related COPD group than in biomass-related COPD
group (Po0.05). There was a positive relationship between DNA damage and MDA
levels in smoking-related COPD group (Po0.05).
Conclusion: Oxidative stress markers and DNA damage were strongly increased in
both patient groups with smoking- and biomass-related COPD. However, DNA is moreElsevier Ltd. All rights reserved.
8. Sk. Cemal gu¨llu¨oglu apt. D:11, 63100 Sanliurfa, Turkey. Tel.: +90 414 314 0216; fax:
oo.com (E. Ceylan).
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Table 1 Characteristics of co
Characteristics Contr
(n ¼
Female gender (%) 14 (3
Age (years) 58.53
BMI (kg/m2) 25.87
FVC, % predicted 93.22
FEV1, % predicted 89.91
FEV1/FVC, % 97.50
Po0.001 vs. smoking-COPD and
DNA damage in chronic obstructive pulmonary disease 1271affected in smoking-related COPD patients than in biomass-related COPD. These
data indicate that cigarette smoking is a more significant DNA damaging risk factor
than biomass smoke.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a
leading cause of chronic morbidity and mortality
and should be a major public health concern.1 It has
been demonstrated that the prevalence of COPD in
adults is approximately 4–6%.2,3 Smoking has been
implicated as the main etiologic factor for the
development of COPD.4 The use of biomass fuel,
such as wood for cooking, also increases the risk of
COPD by three to four times5,6 and may be an
important contributor to COPD prevalence for some
parts of the world, particularly in developing
countries and rural areas.7,8 Oxidative stress is a
major pathogenetic component of the airway
inflammation typical of COPD.4
The development and progression of COPD have
been associated with increased oxidative stress or
reduced antioxidant resources. Several indicators
of oxidative stress, such as hydrogen peroxide
exhalation, lipid peroxidation products and de-
graded proteins, are indeed elevated in COPD
patients.9 The fall in antioxidant capacity of blood
from COPD patients should not only be regarded as
a reflection of the occurrence of oxidative stress
but also as evidence that oxidative stress spreads
out to the circulation and can therefore generate a
systemic effect.9 It has also been shown that COPD
is a predisposition for lung cancer through several
mechanisms including oxidative stress and oxida-
tive stress-mediated processes such as inflamma-
tion and disruption of genomic integrity.9
Cigarette smoke (CS) is a complex mixture
of 44700 chemical compounds of which free
radicals and other oxidants are present in highntrol group and patients w
ol group
36)
Cigarette
(n ¼ 47)
9) 23 (49)
78.8 60.6478
3.4 23.972.5
713.59 45.9716
714.19 35.9712
710.02 64.0715
biomass-COPD.concentrations.10 Oxidative damage is prominent
among the hazardous effects of CS and entails
lipid peroxidation,11 protein oxidation,12 and DNA
damage.13 Biomass smoke, however, contains a
wide range of chemicals that are known or
suspected human carcinogens, and it contains
particle in the small sizes known to penetrate the
deep lung.14,15 In this study we aimed to evaluate
these two COPD-inducing situations by comparing
their oxidative damaging effects on the biomole-
cules which include DNA strands, proteins and
lipids.Materials and methods
Study subjects
The following three groups were studied: 36
healthy non-smokers; 47 patients with smoking-
related COPD and 25 patients with biomass-related
COPD (Table 1). In the biomass-related COPD group,
the exposure to biomass was approximately 2–4 h
per day for at least 10 years. The biomass-related
COPD group consisted of 25 non-smoker women
using biomass for cooking. The cigarette-related
COPD group had a history of 420 pack-years. None
of the COPD patients had been exposed to either
biomass or smoke, respectively, during the last 5
years. The exposures of patients to the biomass
were different in summer and winter times. In
summer, the patients were using the cooker of
which four sides were open and set in their houses’
gardens; however, in winter time they were using it
in a room with approximately an area of 6m2 ofith COPD.
-COPD Biomass-COPD
(n ¼ 25)
P
25 (100) w2 o0.001
.43 59.3279.07 ANOVA 40.05
24.272.3 ANOVA 40.05
.4 49.28715.61 ANOVA o0.001
.6 37.05714.29 ANOVA o0.001
.9 58.37711.38 ANOVA o0.001
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E. Ceylan et al.1272which ventilation was not enough. Since all the
patients were exposed to the biomass at similar
conditions for a similar duration, the rate of
biomass inhalation was approximately similar. The
fuel used for cooking was dung. All the patients had
similar socio-cultural structure since all of them
were from rural areas of the same city. Demo-
graphic features of the cases are given in Table 1.
Patients with COPD had been referred to the Chest
Diseases outpatients clinic at Harran University-
Research Hospital in Sanliurfa. COPD was diagnosed
on the basis of history, physical examination and
spirometric data, according to American Thoracic
Society guidelines.16 All the patients included in
the study had moderate COPD16 with airways
obstruction shown by an FEV1 35–49% of predicted,
a FEV1/FVC ratio of o70% that did not change
markedly for 42 months, no spirometric response
to bronchodilators (i.e. an FEV1 increase of
o 200ml and 15% of baseline values), a history of
chronic progressive symptoms such as dyspnea and
coughing, and a history of smoking or exposure to
biomass. The control group consists of 36 healthy
subjects shown to have normal pulmonary function
(FVC480%, FEV1480%, FEV1/FVC470%). Patients
with COPD were clinically stable. Patients with a
history of atopy or positive results of skin prick
testing for common inhaled allergens and a history
of asthma and18 (i.e. budesonide, 0.8mg/d; or
fluticasone, 1mg/d). Biomass related COPD patient
had been treated with inhaled corticosteroids for a
mean of 1.470.2 year, and smoking related COPD
patients for a mean 1.670.5 year. Inhaled b2
agonists, anticholinergics and theophylline were
also used. This study was performed according to
the European regulations under the supervision of a
bioethics consultant and ethical approval was
obtained.DNA damage determination by alkaline
comet assay
After overnight fasting, 6ml of heparinised periph-
eral blood was collected from each subject, and
processed within 2 h. Separation of mononuclear
cells was performed for the comet assay using the
Histopaque 1077 (Sigmas). An amount of 1ml
heparinised blood was carefully layered over 1ml
Histopaque and centrifuged for 35min at 500g and
25 1C. The interface band containing mononuclear
cells were washed with phosphate buffered saline
(PBS) and then collected by 15min centrifugation
at 400g. The resulting pellets were resuspended in
PBS and the cells were counted in a Neubaer
chamber. Membrane integrity was assessed bymeans of Trypan Blue exclusion method. The
remaining blood was centrifuged at 500g for
10min to obtain the plasma. The separated
plasma was then stored at 80 1C until further
analysis of protein carbonyl (PC) and malondialde-
hyde (MDA).
The endogenous DNA damage in mononuclear
leukocytes was analysed by alkaline comet assay
according to Singh et al.17 with little modification.
Roughened microscope slides were coated with
1.0% hot (60 1C) normal melting point agarose
(NMA) prepared in PBS and then covered with a
coverslip at 4 1C for at least 5min to allow the
agarose to solidify. After removal of coverslips,
slides were and transferred to a humidified box
until used. Mononuclear cells were embedded in
0.7% low-melting-point agarose (LMA) (Sigmas) in
PBS at 37 1C at a final concentration of 104 cells/ml.
80 ml of this cellular suspension was then spread
onto slides that had previously been coated with
NMA, and covered with a coverslip. Slides were
allowed to solidify for 5min at 4 1C in a moist box.
After removing coverlips, 80 ml of 0.7% LMA was
added on the third layer and the slides were placed
with cover slips again in the refrigerator for 5min.
The slides were submersed in freshly prepared cold
(4 1C) lysing solution (2.5M NaCl, 100mM EDTA-Na2;
10mM Tris–HCl, pH 10–10.5; 1% Triton X-100 and
10% DMSO added just before use) for at least 1 h.
Slides were then placed on the horizontal electro-
phoresis unit. The DNA was allowed to unwind for
40min in electrophoresis running buffer solution
(0.3mol/l NaOH, and 1mmol/l Na2EDTA, pH 13).
Subsequently, the tank was set at 25 V (1 V/cm,
300mA) for 25min at an ambient temperature
of 4 1C. All of the above steps (preparation of
slides, lysis and electrophoresis) were conducted
under red light or without direct light in order to
prevent additional DNA damage. After electrophor-
esis, the slides were placed in a horizontal position
and washed three times for 5min each to
remove alkaline and detergent in a neutralisation
buffer (0.4M Tris–HCL, pH 7.5). Finally, 70 ml
ethidium bromide (2 mg/ml) was added to each
slide, which was then covered with a coverslip,
stored in a humidified box at 4 1C and analysed
using a fluorescence microscope (Nikon). Images
of 100 randomly selected cells (50 cells from
each of two replicate slides) were analysed
visually from each subject. Each image was
classified according to the intensity of the fluores-
cence in the comet tail and was given a value of
either 0, 1, 2, 3 or 4 (from undamaged class 0 to
maximally damaged class 4), so that the total score
for the slide ranged between 0 and 400 arbitrary
units.
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Plasma lipid peroxidation was evaluated by the
fluorimetric method based on the reaction between
MDA and thiobarbutiric acid (TBA).18 Briefly 50 ml of
plasma was added to 1ml of 10mmol/l diethylthio-
barbutiric acid (DETBA) reagent in phosphate
buffer (0.1mol/l, pH 3). The mixture was mixed
for 5 s and incubated for 60min at 95 1C. Samples
were placed in ice for 5min and then added 5ml of
n-butanol. The mixture was shaken for 1min to
extract the DETBA-MDA adduct, and then centri-
fuged at 1500g for 10min at 4 1C. Fluorescence of
the butanol extract was measured at excitation
wavelength of 539 and emission wavelength of 553.
1,1,3,3, tetraethoxypropane (Sigmas) was used as
a standard solution and the values were presented
as mmol/l.
Measurement of plasma protein carbonyl
content
Plasma PC level was measured according to Reznick
and Packer.19 Fifteen millilitres of plasma was
treated with 500 ml of 10mmol/l 2,4-dinitrophenyl-
hydrazine (DNPH), dissolved in 2mol/l HCl. Sample
were then incubated for 1 h at room temperature in
the dark and precipitated with 10% trichloracetic
acid (TCA) and centrifuged at 13,000 rpm for 5min.
The pellet was washed three times with 1ml of
ethanol/ethyl acetate, 1/1 (v/v) and redissolved in
1ml of 6mol/l guanidine in 10mmol/l phosphate
buffer/trifluoroacetic acid (pH 2.3). The difference
in absorbance between the DNPH-treated and the
HCl-treated samples was determined at 366 nm.
The results were expressed as nmol of carbonyl
groups per mg protein, using the extinction
coefficient of 22,000M1 cm1 for aliphatic hydra-
zones.
Statistical analysis
Data were analysed using SPSSs for Windows
computing program (Version 11.0). Results are
presented as mean7SD or frequency expressed as
a percent. Categorical variables were compared
using w2 tests. Comparison among multiple groups
was performed by one-way analysis of variance
(ANOVA) with LSD post hoc test for continuous
variables. Difference of DNA strand breaks values
among the groups was demonstrated by a Simple
Error Bar graph. Association of DNA strand breaks
values with MDA levels was assessed by Pearson
correlation coefficient. A 2-tailed P value o0.05
was considered statistically significant.Results
Demographic characteristics of the subjects are
shown in Table 1. As seen in the Table 1, the
smoking-related COPD, biomass-related COPD pa-
tients and matched controls were similar ranges in
terms of age, height, body weight, and body mass
index (BMI) (P40.05). More women were included
in the COPD groups, especially in the biomass-
related COPD group, compared to controls (w2;
Po0.001).
In all individuals, DNA strand breaks values did
not correlated with MDA content (n ¼ 109,
r ¼ 0:119, P ¼ 0:412). When correlation tests were
performed, there was a positive relationship
between DNA damage and MDA content in the
smoking-related COPD group (n ¼ 47, r ¼ 0:49,
P ¼ 0:018). But, there was not significant correla-
tion between these parameters in the control group
(n ¼ 37, r ¼ 0:112, P ¼ 0:716) or the biomass-
related COPD group (n ¼ 25, r ¼ 0:332, P ¼ 0:246).
The mean values of DNA strand breaks, MDA and
protein carbonyl levels were significantly higher in
smoking- and biomass-related COPD groups than in
the control group (ANOVA Po0.001, o0.05 and
o0.05, respectively). DNA damage levels were also
higher in smoking-related COPD group than in
biomass-related COPD group (Po0.05) (Fig. 1).
However, MDA and PC levels were not significantly
different between these two groups (smoking-
related COPD group and biomass-related COPD)
(P40.05). There was a positive relationship be-
tween DNA damage and MDA content in smoking-
related COPD group (r ¼ 0:490, Po0.05). The
results are summarised in Table 2.Discussion
It is known that oxidative stress is a major
pathogenetic component of the airway inflamma-
tion that is characteristic for COPD.4 Oxidative
radicals are known to cause oxidative damage to a
number of different molecules in cellular compo-
nents including membrane lipids, proteins, carbo-
hydrates, and DNA.20 Both CS and biomass contain a
lot of oxidative and chemical agents, and these
agents can damage the biomolecules such as
protein, lipid, and DNA. It is well known that both
cigarette smoking and biomass exposure cause
COPD in which free radicals and reactive oxygen
metabolites increase,16,21,22 however, it is still
unclear that which one of the biomolecules is more
affected by these agents. Therefore, we performed
this study and compared the effects of CS and
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Figure 1 Mononuclear leukocytes DNA damage values of the patients and control groups.
Table 2 Comparative analysis of oxidative stress markers in patients with biomass-COPD, smoking-COPD and
control group.
Parameters Control group
n ¼ 37
Biomass-COPD
n ¼ 25
Smoking-COPD
n ¼ 47
P
Mononuclear leukocytes DNA
damage (arbitrary units)
60.55737.34 97.71745.88y 120.50759.48 o0.001
Plasma MDA levels (micromol/l) 3.4371.89z 4.7871.81 4.3471.95 o0.05
Plasma carbonyl content (nmol/
mgprot)
1.6370.94y 2.9071.45 2.6771.74 o0.05
P ¼ 0.022 vs. biomass-COPD and Po0.001 vs. smoking-COPD.
yP ¼ 0.038 vs. smoking-COPD.
zP ¼ 0.016 vs. biomass-COPD and P ¼ 0.066 vs. smoking-COPD.
yP ¼ 0.021 vs. biomass-COPD and P ¼ 0.032 vs. smoking-COPD.
E. Ceylan et al.1274biomass exposure on oxidative stress markers such
as plasma MDA and PC, and mononuclear DNA
damage in patients with COPD.
Oxidative damage to DNA is of great importance
because of the growing recognition that such
damage may both initiate and promote carcinogen-
esis.23,24 Within the last decade, human peripheral
mononuclear leukocytes have been used to monitorenvironmentally induced genetic damage by differ-
ent methods, such as micronuclei, chromosome
aberration, sister chromatin exchange.25 Among
various assays for measuring DNA damage, single-
cell gel electrophoresis assay (comet assay) is a
sensitive and powerful method for determining DNA
strand break,26 and we, therefore, employed it in
this study.
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DNA damage in chronic obstructive pulmonary disease 1275It has been reported that the strands breaks arise
from generated DNA damage including oxidative
stress.27 We found that DNA damage was signifi-
cantly higher in both smoking- and biomass-related
COPD, in which oxidatively stressful events occur,
compared to the control subjects. The damage was
also significantly higher in smoking- related COPD
group than in biomass-related COPD group.
Both CS16 and biomass21,22 result in exposure to a
variety of chemical agents which cause oxidative
damage. However, it was exactly not known which
agents cause more DNA damage. Although some
previous studies demonstrated that cigarette smok-
ing cause oxidative DNA damage,13 this is the first
study to show a relationship between biomass and
DNA damage. The strong epidemiological relation-
ship between tobacco smoking and increased risk of
several types of cancer, together with experimental
studies, suggest that carcinogenic nitrosamines,
polycyclic aromatic hydrocarbons, aromatic
amines, and additional toxic compounds in CS
reach target cells to exert their carcinogenic and
co-carcinogenic actions.28 However, there is no
study implicating any relationship between cancer
and biomass exposure. Our findings demonstrate
that both cigarette smoking and biomass exposure
may be associated with increased DNA damage,
although CS has more effects than biomass ex-
posure in patients with COPD.
In this study, we found that plasma MDA levels, as
an indicator of lipid peroxidation, were signifi-
cantly higher in both smoking- and biomass-related
COPD, compared to the control subjects. Polyunsa-
turated fats and fatty acids are major target for
free radical attack, resulting in lipid peroxidation,
a process that may continue as a chain reaction to
generate peroxides and aldehydes. Products of lipid
peroxidation reactions can be measured in body
fluids as TBA reactive substances (TBARS). COPD is
a risk factor for oxidative stress on its own. It has
been shown that the levels of TBARS in plasma are
significantly higher in COPD, and the levels of
TBARS in plasma are correlated inversely with the
percent predicted FEV1 in a population study.
29–31
There are some studies indicating the increased
levels of lipid peroxidation in both cigarette
smoking and biomass exposure.32 Gani et al.32
reported that there was a significant increase in
lipid peroxidation activity and a significant de-
crease in antioxidant enzyme activity in females
exposed to biomass fuels. They also demonstrated
that the levels of TBARS in plasma or in BALF, were
significantly increased in healthy smokers.29,31 Our
findings also support their report.
Protein carbonyl content was significantly higher
in both smoking- and biomass-related COPD than incontrol subjects. Protein carbonyl content was also
higher in biomass-related COPD than in smoking-
related COPD, however, this difference was not
statistically significant. In the case of proteins,
almost all amino acids can be oxidised by reactive
oxygen species, but the sulphur-containing
(cysteine and methionine) amino acids are among
the most susceptible. Metal-bound amino acids are
also specific targets for metal-catalysed oxidative
damage.33 Previously, several studies have demon-
strated that cigarette smoking causes oxidation of
protein thiols, and alterations in protein carbonyl
content in plasma,12 and potency of cigarette
smoking is revealed by its capacity to oxidise
proteins.34 The gas phase cigarette smoking-in-
duced oxidative damage of proteins occurs possibly
because of the fact that it comprises three times as
many active components compared to the tar
phases.35,36 Although there have been no previous
reports about biomass and protein oxidation, we
have demonstrated that protein oxidation was
higher in biomass-related COPD than in smoking-
related COPD. However, the difference was not
statistically significant. Protein carbonyl content
was significantly higher in both smoking- and
biomass-related COPD than in control subjects.
In conclusion, oxidative stress markers are
strongly affected in both patients with smoking-
and biomass-related COPD. However, DNA is more
affected in smoking-related COPD patients than in
biomass-related COPD patients. These data indi-
cate that CS may contain more DNA damaging
agents than biomass smoke.Acknowledgements
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